Literature DB >> 32205113

Rapid-Deployment Aortic Valves for Patients With a Small Aortic Root: A Single-Center Experience.

Iuliana Coti1, Thomas Haberl1, Sabine Scherzer1, Shiva Shabanian1, Thomas Binder2, Alfred Kocher1, Guenther Laufer1, Martin Andreas3.   

Abstract

BACKGROUND: Aortic valve replacement in patients with a small aortic root is a matter of concern in terms of prosthesis-patient mismatch. We evaluated the survival and hemodynamic performance after implantation of a small rapid-deployment aortic valve (EDWARDS INTUITY valve system sizes 19 and 21 mm).
METHODS: Between May 2010 and November 2018, 659 consecutive patients with severe aortic stenosis who received a rapid-deployment valve were included in a prospective and ongoing database. A small aortic bioprosthesis (sizes 19 mm and 21 mm) was implanted in 217 (32.9%) patients (mean age 74.9 ± 7.9 years, 85.3% women). Preoperative characteristics, operative parameters, and postoperative outcomes were assessed.
RESULTS: Mean gradients at discharge and 1 year were 14.8 ± 5.6 mm Hg and 13.6 ± 4.9 mm Hg, respectively. Mean effective orifice area and the indexed effective orifice area at discharge were 1.55 ± 0.36 cm2 and 0.87 ± 0.22 cm2/m2, respectively, and prosthesis-patient mismatch occurred in 77 (35.5%) patients (25.8% moderate and 9.7% severe). Perioperative mortality was 1.8% (n = 4 of 217) and overall survival at 1 year and 5 years was 91% and 79%, respectively. The presence of any prosthesis-patient mismatch degree did not have a significant influence on overall survival (hazard ratio, 0.95; 95% confidence interval, 0.75-1.19; P = .638). At the last follow-up, mean New York Heart Association functional class was 1.5 ± 0.7 vs 2.8 ± 0.6 at baseline (P < .001).
CONCLUSIONS: Surgical aortic valve replacement with rapid-deployment valves has shown improved results concerning hemodynamic performance, with decreased rates of prosthesis-patient mismatch. We observed excellent early-term and midterm survival and a significant improvement in functional class in this subgroup of patients with a small annulus.
Copyright © 2020 The Society of Thoracic Surgeons. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2020        PMID: 32205113     DOI: 10.1016/j.athoracsur.2020.02.030

Source DB:  PubMed          Journal:  Ann Thorac Surg        ISSN: 0003-4975            Impact factor:   4.330


  5 in total

1.  Outcome of rapid deployment aortic valves: long-term experience after 700 implants.

Authors:  Iuliana Coti; Thomas Haberl; Sabine Scherzer; Paul Werner; Shiva Shabanian; Alfred Kocher; Guenther Laufer; Martin Andreas
Journal:  Ann Cardiothorac Surg       Date:  2020-07

2.  Effect of conventional and rapid-deployment aortic valve replacement on the distance from the aortic annulus to coronary arteries.

Authors:  Iuliana Coti; Udo Maierhofer; Claus Rath; Paul Werner; Christian Loewe; Alfred Kocher; Guenther Laufer; Martin Andreas
Journal:  Interact Cardiovasc Thorac Surg       Date:  2021-01-22

3.  Long-Term Results (up to 20 Years) of 19 mm or Smaller Prostheses in the Aortic Position. Does Size Matter? A Propensity-Matched Survival Analysis.

Authors:  Horea Feier; Andrei Grigorescu; Lucian Falnita; Oana Rachita; Marian Gaspar; Constantin T Luca
Journal:  J Clin Med       Date:  2021-05-11       Impact factor: 4.241

4.  Peri-procedural Trans-esophageal Echocardiographic Sizing of the Native Left Ventricular Outflow Tract During Edwards INTUITY Valve Implantation.

Authors:  Kevin Lim; Yan Kit Ho; Simon Chi Ying Chow; Takuya Fujikawa; Alex Pui-Wai Lee; Randolph Hung Leung Wong
Journal:  Front Cardiovasc Med       Date:  2021-07-15

5.  Mid-term outcomes of rapid deployment aortic prostheses in patients with small aortic annulus.

Authors:  José M Arribas-Leal; José Miguel Rivera-Caravaca; Ramón Aranda-Domene; José A Moreno-Moreno; Dolores Espinosa-Garcia; Antonio Jimenez-Aceituna; Joaquín Perez-Andreu; Rubén Taboada-Martin; Daniel R Saura-Espin; Sergio J Canovas-Lopez
Journal:  Interact Cardiovasc Thorac Surg       Date:  2021-10-29
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.